Table 3.
All-Cause and Disease-Related Medical and Pharmacy Utilization by Condition
| ER Visits | Hospitalizations | Outpatient Medical Visits | Pharmacy Fills | |
|---|---|---|---|---|
| All-Cause Utilization* | ||||
| Asthma | ||||
| % of patients with ≥ 1 visit/fill | 14% | 5% | 98% | 87% |
| (Mean #)€ | (1.9) | (1.5) | (13.7) | (14.3) |
| COPD | ||||
| % with ≥ 1 visit/fill | 18% | 13% | 99% | 91% |
| (Mean #)€ | (2.2) | (1.8) | (16.4) | (20.0) |
| Coronary artery disease | ||||
| % with ≥ 1 visit/fill | 13% | 10% | 99% | 88% |
| (Mean #)€ | (2.1) | (1.8) | (13.3) | (19.2) |
| Diabetes | ||||
| % with ≥ 1 visit/fill | 14% | 8% | 99% | 92% |
| (Mean #)€ | (2.0) | (2.0) | (15.1) | (21.2) |
| Heart failure | ||||
| % with ≥ 1 visit/fill | 22% | 18% | 99% | 93% |
| (Mean #)€ | (2.5) | (2.5) | (19.2) | (25.3) |
| Hyperlipidemia | ||||
| % with ≥ 1 visit/fill | 9% | 4% | 98% | 82% |
| (Mean #)€ | (1.6) | (1.6) | (11.4) | (12.9) |
| Disease-Related Utilization** | ||||
| Asthma | ||||
| % with ≥ 1 visit/fill | 1% | 0.7% | 32% | 67% |
| (Mean #)€ | 1.3 | 1.0 | 1.8 | 5.1 |
| COPD | ||||
| % with ≥ 1 visit/fill | 2% | 2% | 37% | 62% |
| (Mean #)€ | 1.7 | 1.4 | 2.4 | 6.9 |
| Coronary artery disease | ||||
| % with ≥ 1 visit/fill | 1% | 2% | 35% | 86% |
| (Mean #)€ | 1.2 | 1.4 | 1.9 | 13.4 |
| Diabetes | ||||
| % with ≥ 1 visit/fill | 1% | 1% | 74% | 83% |
| (Mean #)€ | 1.2 | 1.2 | 2.9 | 9.3 |
| Heart failure | ||||
| % with ≥ 1 visit/fill | 3% | 3% | 26% | 91% |
| (Mean #)€ | 1.4 | 1.5 | 2.6 | 18.2 |
| Hyperlipidemia | ||||
| % with ≥ 1 visit/fill | 0.4% | None | 25% | 62% |
| (Mean #)€ | 1.1 | 1.4 | 3.6 | |
*
Any medical visit or pharmacy fill for relevant condition population.
**
Condition-specific medical visit with primary ICD-9 code per Table 1 and Condition-specific pharmacy fill per Table 1.
€
Mean number of visits or medication fills in patients with ≥ 1 visit or ≥ 1 medication fill.
ER, emergency room; COPD, chronic obstructive pulmonary disease.